These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16299429)

  • 21. Physician attitudes toward human growth hormone products.
    Nelson WW; Frear RS
    Am J Health Syst Pharm; 1999 Jan; 56(1):51-6. PubMed ID: 10048879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue.
    Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Katsumata N; Tachibana K; Nose O; Hibi I
    Acta Paediatr Suppl; 1999 Feb; 88(428):85-8. PubMed ID: 10102060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dilemmas of growth hormone treatment for GH deficiency and idiopathic short stature: defining, distinguishing, and deciding.
    Halas JG; Grimberg A
    Minerva Pediatr; 2020 Jun; 72(3):206-225. PubMed ID: 32274914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of GH-deficient children with two different GH doses: effect on final height and cost-benefit implications.
    Radetti G; Buzi F; Paganini C; Pilotta A; Felappi B
    Eur J Endocrinol; 2003 May; 148(5):515-8. PubMed ID: 12720533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short- and long-term (final height) growth responses to growth hormone (GH) therapy in patients with Turner syndrome: correlation of growth response to stimulated GH levels, spontaneous GH secretion, and karyotype.
    Schmitt K; Haeusler G; Blümel P; Plöchl E; Frisch H
    Horm Res; 1997; 47(2):67-72. PubMed ID: 9030970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Favorable final height outcome in girls with Ullrich-Turner syndrome treated with low-dose growth hormone together with oxandrolone despite starting treatment after 10 years of age.
    Stahnke N; Keller E; Landy H;
    J Pediatr Endocrinol Metab; 2002 Feb; 15(2):129-38. PubMed ID: 11874177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality of life of growth hormone (GH) deficient young adults during discontinuation and restart of GH therapy.
    Stouthart PJ; Deijen JB; Roffel M; Delemarre-van de Waal HA
    Psychoneuroendocrinology; 2003 Jul; 28(5):612-26. PubMed ID: 12727130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Final height in idiopathic growth hormone deficiency: the KIGS experience. KIGS International Board.
    Cutfield W; Lindberg A; Albertsson Wikland K; Chatelain P; Ranke MB; Wilton P
    Acta Paediatr Suppl; 1999 Feb; 88(428):72-5. PubMed ID: 10102057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of growth hormone treatment in children with cystic fibrosis: the National Cooperative Growth Study experience.
    Hardin DS; Sy JP
    J Pediatr; 1997 Jul; 131(1 Pt 2):S65-9. PubMed ID: 9255232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current practice in diagnosis and treatment of growth hormone deficiency in childhood: a survey from Turkey.
    Poyrazoğlu Ş; Akçay T; Arslanoğlu İ; Atabek ME; Atay Z; Berberoğlu M; Bereket A; Bideci A; Bircan İ; Böber E; Can Ş; Cesur Y; Darcan Ş; Demir K; Dündar B; Ersoy B; Esen İ; Güven A; Kara C; Keskin M; Kurtoğlu S; Memioğlu N; Özbek MN; Özgen T; Sarı E; Şıklar Z; Şimşek E; Turan S; Yeşilkaya E; Yüksel B; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2015 Mar; 7(1):37-44. PubMed ID: 25800474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
    Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A review of biopsychosocial strategies to prevent and overcome early-recognized poor adherence in growth hormone therapy of children.
    Haverkamp F; Gasteyger C
    J Med Econ; 2011; 14(4):448-57. PubMed ID: 21651428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of recombinant growth hormone treatment on children with Crohn's disease and short stature: a pilot study.
    Calenda KA; Schornagel IL; Sadeghi-Nejad A; Grand RJ
    Inflamm Bowel Dis; 2005 May; 11(5):435-41. PubMed ID: 15867582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A pilot study of growth hormone administration in boys with predicted adult short stature and near-ending growth.
    Rothenbuhler A; Ormières B; Kalifa G; Bougnères P
    Growth Horm IGF Res; 2015 Apr; 25(2):96-102. PubMed ID: 25641639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac dimension and function in patients with childhood onset growth hormone deficiency, before and after growth hormone retreatment in adult age.
    Feinberg MS; Scheinowitz M; Laron Z
    Am Heart J; 2003 Mar; 145(3):549-53. PubMed ID: 12660681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GH Dose Reduction Maintains Normal Prepubertal Height Velocity After Initial Catch-Up Growth in Short Children.
    Decker R; Albertsson-Wikland K; Kriström B; Halldin M; Gustafsson J; Nilsson NÖ; Dahlgren J
    J Clin Endocrinol Metab; 2019 Mar; 104(3):835-844. PubMed ID: 30339244
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GH and GnRH analog treatment in children who enter puberty at short stature.
    Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Hibi I
    J Pediatr Endocrinol Metab; 1997; 10(6):623-8. PubMed ID: 9467133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose growth hormone (GH) treatment in prepubertal GH-deficient children.
    Yokoya S; Araki K; Igarashi Y; Kohno H; Nishi Y; Hasegawa Y; Fujita K; Iwatani N; Tachibana K; Ohyama Y; Seino Y; Satoh M; Fujieda K; Tanaka T
    Acta Paediatr Suppl; 1999 Feb; 88(428):76-9. PubMed ID: 10102058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth.
    Drake WM; Carroll PV; Maher KT; Metcalfe KA; Camacho-Hübner C; Shaw NJ; Dunger DB; Cheetham TD; Savage MO; Monson JP
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1658-63. PubMed ID: 12679453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.